• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

NewHope Bariatrics Surgeon Honored for 1,000th LAP-BAND(R) Procedure for Surgical Weight Loss

Posted on: Thursday, 19 June 2008, 09:01 CDT

NewHope Bariatrics announced today that the Medical Director of the NewHope Bariatrics Surgery Center, Stephen Malley, M.D., has performed his 1,000th LAP-BAND(R) System procedure - the safest, least invasive surgery available to treat severe obesity. Dr. Malley will be honored for his achievements in the field of bariatric surgery on Saturday at a private event in Kansas City.

"I've made a life-long commitment to provide the best treatment options to my patients," said Dr. Malley. "It is rewarding to help the seriously overweight patient population in the greater Kansas City area lose dangerous excess weight and lead healthier, happier lives."

The LAP-BAND(R) System is one of the only weight-loss surgical options that can be performed in an outpatient surgery center. The procedure is performed laparoscopically, typically in less than one hour, and patients return home the same day. It is also the only reversible weight-loss surgery. The LAP-BAND(R) System procedure is significantly safer than the gastric bypass, which requires the cutting and stapling of the stomach and intestines, and has a mortality rate of 1 in 200.(i)

Obesity is a growing epidemic in the United States. According to the fourth annual F as in Fat: How Obesity Policies Are Failing in America, 2007 report from the Trust for America's Health, adult obesity rates over the past year rose in 31 states, including Kansas, which was ranked as the 27th highest rate of adult obesity at 24.3 percent. Obesity can lead to serious health consequences, including type 2 diabetes and even premature death.

Data strongly supports surgical treatment as a superior option for weight loss in severely obese patients and as a means to help control comorbidities associated with excess weight like Type 2 diabetes and hypertension.(ii,iii)

NewHope Bariatrics and Dr. Stephen Malley offer a comprehensive program beginning with extensive education, pre-surgical consultation and financial counseling, and continuing through aftercare programs focused on long-term clinical support and access to a community of patients and health-care professionals. The entire program is designed to help people achieve their weight loss goals and improve their quality of life.

One of the most experienced bariatric surgeons in the Midwest, Dr. Malley also serves as a LAP-BAND(R) surgical proctor for Allergan, Inc. (NYSE: AGN), the product's manufacturer, teaching other surgeons how to perform this laparoscopic procedure.

The NewHope Bariatrics Obesity Surgery Center is located at 10787 Nall Avenue, Suite 100, Overland Park, Kansas. Free educational seminars are offered to the public. To register or to find out more information, please call 1-877-NEW-HOPE (1-877-639-4673) or visit www.newhopetoday.com.

NewHope Bariatrics (Charlotte, N.C.) develops and operates ambulatory surgery centers and short-stay surgical hospitals in partnership with highly regarded bariatric surgeons that serve the needs of the seriously overweight. The NewHope Bariatric Centers focus on adjustable gastric banding procedures (primarily the LAP-BAND(R) System), delivering compassionate care, excellent clinical results, and superior patient satisfaction ratings. For more information, visit www.newhopebariatrics.com.

(i) Chapman A, Game P, O'Brien P, Maddern G, Kiroff G, Foster B, Ham J. Executive summary: Laparoscopic adjustable gastric banding for the treatment of obesity: Update and re-appraisal. Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S) Report No. 31, Second Edition. Adelaide, South Australia: ASERNIP-S, June 2002. (Laparoscopic adjustable gastric banding surgery, like the LAP-BAND(R) surgery, is associated with a mean short-term mortality rate of around 0.05% compared to 0.50% for Gastric Bypass and 0.31% for Vertical Banded Gastroplasty.)

(ii) Shekelle PG, Morton SC, Maglione M, Suttorp M, Tu W, Li Z, Maggard M, Mojica WA, Shugarman L, Solomon V. Pharmacological and Surgical Treatment of Obesity., Evidence Report/Technology Assessment No. 103. (Prepared by the Southern California-RAND Evidence-based Practice Center, under Contract No. 290-02-0003.) AHRQ Publication No. 04-E028-1. Rockville, MD: Agency for Healthcare Research and Quality. July 2004.

(iii) Muscelli E, Mingrone G, Camastra S et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005; 118: 51-7.

Source: Business Wire

More News in this Category